J&J Unit Fights Use Of New Topamax Label In Defect Suits
A Johnson & Johnson unit said Tuesday that plaintiffs in a cluster of suits alleging that the anti-epilepsy drug Topamax caused birth defects had improperly asked a Pennsylvania judge to reconsider...To view the full article, register now.
Already a subscriber? Click here to view full article